Lockheed Martin Signs Non-Binding MOU to Purchase NioCorp Scandium
Read source articleWhat happened
NioCorp Developments announced a non-binding memorandum of understanding with Lockheed Martin for the potential purchase of up to 15 tonnes per year of scandium oxide, or aluminum-scandium alloys, over a 10-year period. This agreement expands on their existing Pentagon-funded joint development program under the DoD’s Title III, which aims to create a domestic scandium supply chain for defense applications. The MOU signals Lockheed Martin’s commercial interest beyond research but remains non-binding, leaving price, term, and definitive volume open to negotiation. For NioCorp, this directly targets one of the key de-risking items identified in prior analysis: converting offtake discussions into credible agreements that strengthen the project’s bankability. While the MOU does not provide immediate revenue, it reinforces the strategic value of the Elk Creek project and may improve the company’s standing in EXIM debt financing discussions.
Implication
Investors should treat this MOU as a step toward, but not a replacement for, binding offtake agreements critical for securing EXIM project debt. The Lockheed Martin name adds credibility and aligns with U.S. critical-minerals policy, but until terms are finalized, the financial impact is contingent. This development emerges after the Yorkville equity facility’s expiration, so the company still needs to demonstrate a committed funding path. The MOU may accelerate EXIM due diligence and could lead to a definitive agreement, but milestones like definitive offtake and formal EXIM approval remain the true catalysts. In the near term, the stock may react positively, but sustained value creation depends on binding contracts and closing the capital stack, so position sizing should reflect the non-binding nature and the ongoing execution risks of a pre-revenue project with a $1.14 billion capex requirement.
Thesis delta
The Lockheed MOU shifts the thesis from pure speculation to a tangible, albeit non-binding, customer indication, directly addressing the prior offtake gap for scandium, where only 12% was committed under a non-binding term sheet. This increases the probability that NioCorp can present a comprehensive offtake package to lenders, supporting the pathway to EXIM financing. However, the thesis still hinges on converting this and other offtakes into definitive contracts and securing committed non-dilutive funding before cash reserves are depleted.
Confidence
Moderate